FINWIRES · TerminalLIVE
FINWIRES

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

By

-- European equities traded in the US as American depositary receipts rose late Thursday morning, gaining 2.20% to 1,818.51 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk (NVO) and lender ING Groep (ING), which advanced 5.3% and 4.9% respectively. They were followed by biopharmaceutical firm Grifols (GRFS) and consumer goods firm Unilever (UL), which rose 3.2% and 3.1% respectively.

The decliners from continental Europe were led by internet advertising firm Criteo (CRTO) and telecommunications company Nokia (NOK), which fell 3.2% and 1.9% respectively.

The gainers from the UK were led by cruise line operator Carnival (CUK) and utilities company National Grid (NGG), which rose 4.8% and 3.5% respectively. They were followed by Lloyds Banking Group (LYG) and telecommunications operator Vodafone Group (VOD), which were up 2.6% and 2.3% respectively.

The decliners from the UK and Ireland were led by software firm Endava (DAVA) and Bicycle Therapeutics (BCYC), which lost 5.2% and 2.3% respectively. They were followed by biopharmaceutical companies Amarin (AMRN) and Mereo BioPharma Group (MREO), which fell 1.3% and 0.9% respectively.

Related Articles

Australia

Amazon's Backlog Ramp Points to Accelerating Revenue Growth, UBS Says

Amazon's (AMZN) backlog ramp, including $100 billion from Anthropic, points to accelerating revenue growth in 2026 and 2027, UBS said in a Thursday report."While there may still be some variability on the magnitude, the backlog ramp continues to point the way to accelerating revenue growth throughout 2026 and 2027, which should in turn raise investor confidence on ROIC," the note said. ROIC refers to return on invested capital.For 2026, the base case for Amazon Web Services growth is now 36%, the report said, adding that consolidated near-term revenue estimates have also moved up, driven by the e-commerce business following Q1 beat.UBS reiterated its buy rating and boosted its price target to $333 from $304.Price: $259.19, Change: $-3.85, Percent Change: -1.46%

$AMZN
Australia

Wells Fargo Adjusts Price Target on CoStar Group to $33 From $40

CoStar Group (CSGP) has an average rating of overweight and mean price target of $50.33, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $34.15, Change: $+0.01, Percent Change: +0.03%

$CSGP
Australia

Morgan Stanley Adjusts Price Target on AbbVie to $278 From $270

AbbVie (ABBV) has an average rating of overweight and mean price target of $253.15, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $213.21, Change: $+9.32, Percent Change: +4.57%

$ABBV